Loading…
Based on limited metadata, Kingston Pharma LLC, a pharmaceutical drug manufacturer, received an FDA Warning Letter on May 14, 2019. While the specific violations cannot be detailed without access to the full letter text, the warning was issued under FDA's drug regulatory authority. Additional details regarding the nature of the violations and the specific issuing office are not available in the provided metadata.